SCHEMBL7420510

SCHEMBL7420510

CCCc1cc2ccc(C(=O)OC)cc2[nH]1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
MEN1 O00255 2/20 0.53
ATM Q13315 1/20 0.53
MTNR1A P48039 2/20 0.49
MTNR1B P49286 2/20 0.49
KIF11 P52732 1/20 0.47
KDM4E B2RXH2 3/20 0.45
ALDH1A1 P00352 3/20 0.45
HTT P42858 2/20 0.45
NPC1 O15118 1/20 0.45
LMNA P02545 1/20 0.45
PARP1 P09874 2/20 0.44
RAB9A P51151 1/20 0.43
CREBBP Q92793 1/20 0.43
HPGD P15428 2/20 0.42
HSD17B10 Q99714 2/20 0.42
PSMB8 P28062 1/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7411302 0.92 L3MBTL1 (0.48) KMT2AL3MBTL1MEN1ATMMTNR1A
SCHEMBL10983062 0.89 MEN1 (0.46) KMT2AL3MBTL1MEN1ATMMTNR1A
SCHEMBL10982423 0.89 MEN1 (0.46) KMT2AL3MBTL1MEN1ATMMTNR1A
SCHEMBL10984403 0.89 MEN1 (0.46) KMT2AL3MBTL1MEN1ATMMTNR1A
SCHEMBL5882041 0.89 MEN1 (0.56) KMT2AL3MBTL1MEN1ATMMTNR1A
SCHEMBL5881814 0.88 KIF11 (0.49) KMT2AL3MBTL1MEN1ATMMTNR1A
SCHEMBL7473980 0.86 MTNR1A (0.47) KMT2AL3MBTL1MEN1ATMMTNR1A
SCHEMBL7468896 0.84 KIF11 (0.48) KMT2AL3MBTL1MEN1ATMMTNR1A
SCHEMBL7420103 0.84 MTNR1A (0.45) KMT2AL3MBTL1MEN1ATMMTNR1A
SCHEMBL5981755 0.84 CASP3 (0.51) KMT2AMTNR1AMTNR1BKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
CN-1187812-A Indole derivatives as CGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO (JP) 1998-07-15 CN disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed